Arecor Therapeutics plc (AREC.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 30.39M |
| Enterprise Value | 27.49M |
| P/E Ratio | 165 |
| PEG Ratio | -4.03 |
| Price/Sales Ratio | -393.4 |
| Price/Book Ratio | 8.46 |
| Enterprise/Revenue | -376.78 |
| Enterprise/EBITDA | -6.91 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2 |
| Operating Margin | 51.14 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 1.71M |
| Revenue/Share | -0 |
| Gross Profit | 1.05M |
| EBITDA | -4.45M |
| Net Income | 664,000 |
| Diluted EPS | 0.02 |
Balance Sheet
| Total Cash | 3.16M |
| Total Cash/Share | 0.08 |
| Total Debt | 57,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 4.29 |
| Book Value Per Share | 0.1 |
Price History
| 52-Week Change | 15.38 |
| 52-Week High | 95 |
| 52-Week Low | 55.27 |
| Moving Average 50 Days | 75.9 |
| Moving Average 200 Days | 70 |
Statistics
| Average Volume | 32,795 |
| Shares Outstanding | 45.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
